Home  >  Speakers  >  Kevin Dack
Kevin Dack

Kevin Dack

    
Ballerup, Copenhagen (Hovedstaden)    Denmark
Addiction Medicine
Addiction Medicine, Drug Technology,...More
Spoken at 1 event

Biography :

Kevin Dack joined Pfizer UK in 1982 after studying chemistry at the University of Southampton. During his almost 30 years at the Sandwich Labs, Kevin was an inventor or contributor for over 15 nominated candidates, including two marketed drugs (voriconazole & darifenacin), with more than 50 publications and patents. As an associate research fellow, Kevin was actively involved in partnering with the Pfizer Compound Safety Prediction group to help establish a 'Compound Safety Evaluation Toolkit' that included avoiding drug/target promiscuity as a driver for safer drugs. Kevin is a fellow of the Royal Society of Chemistry (FRSC) and a Chartered Chemist (CChem), and he was awarded a Technical Achievement in organic chemistry (TAOC) by the ACS in 2007. In 2011, Kevin moved to Copenhagen, Denmark to join LEO Pharma, specializing in dermatology. He is currently the drug technology lead at LEO Global Research, with interests that include oral small-molecule, protein-protein interaction inhibitors and topical 'soft drug' design.

**********************
*** ** ** ** **
 
For speaker's contact information - Contact us

Specialties

Addiction Medicine

Interested Topics

Addiction Medicine, Drug Technology, Medicinal Chemistry, Pharmacology, Dermatology, Drug Metabolism, Drug Safety

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
X

Send Message

Convert
Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.